What enzymes are in BioCore AminoTap?

BioCore AminoTap is a proprietary protease blend that includes multiple classes of proteolytic enzymes—typically acid-stable aspartic proteases functional at gastric pH 2–4, serine endoproteases with trypsin- and chymotrypsin-like activity at neutral pH, and metalloproteases active in the intestinal pH range of 6–8. This combination is designed to provide broad-spectrum peptide bond cleavage across arginine, lysine, hydrophobic, and aromatic residues. The exact species-specific enzyme strains and activity units (HUT, SAPU, PC) are proprietary to the manufacturer.

Does BioCore AminoTap actually improve protein absorption?

In vitro digestion models sponsored by the manufacturer show significantly elevated free BCAA and glutamine concentrations when BioCore AminoTap is added to protein substrates versus unassisted digestion, suggesting enhanced proteolytic efficiency. However, no published peer-reviewed human trials currently confirm that these in vitro increases translate to measurably higher plasma amino acid concentrations or improved muscle protein synthesis in vivo. Healthy individuals with intact pancreatic enzyme secretion may see minimal additional benefit, whereas those with exocrine pancreatic insufficiency or low stomach acid (hypochlorhydria) may derive more meaningful digestive support.

When should I take BioCore AminoTap for best results?

Protease enzyme blends like BioCore AminoTap are generally recommended to be taken immediately before or at the start of a protein-containing meal so that enzymes are present in the stomach and small intestine concurrently with the protein substrate. Taking enzymes 30 or more minutes before eating or long after a meal reduces the opportunity for enzymatic contact with dietary protein. Products containing BioCore AminoTap are often included in post-workout protein supplements, in which case timing follows protein intake recommendations—typically within 1–2 hours of resistance exercise.

Is BioCore AminoTap safe to take daily?

Oral digestive protease enzymes derived from microbial or plant sources have a well-established safety profile at typical supplemental doses, and daily use is considered low-risk for most healthy adults. BioCore AminoTap, like similar enzyme blends, is unlikely to cause systemic toxicity because proteases are largely inactivated and digested within the gastrointestinal tract rather than absorbed intact. The primary risks associated with daily use include potential GI sensitivity in individuals with mucosal inflammation or existing digestive conditions, and possible allergic responses in those sensitive to the fungal fermentation sources used to produce the enzymes.

How does BioCore AminoTap compare to bromelain or papain for protein digestion?

Bromelain (from pineapple) and papain (from papaya) are cysteine proteases with relatively narrow pH optima—bromelain is most active between pH 5–8 and papain between pH 5–7—making them less effective in the highly acidic stomach environment. BioCore AminoTap's multi-enzyme formulation is specifically designed to include acid-stable proteases active at gastric pH 2–4 in addition to neutral-pH enzymes, theoretically providing more complete digestion throughout the entire GI tract. Unlike single-enzyme sources, BioCore AminoTap targets multiple peptide bond types simultaneously, which in vitro data suggest increases the breadth of amino acid liberation, particularly of BCAAs and glutamine compared to bromelain or papain alone.

What is the evidence quality for BioCore AminoTap's amino acid release claims?

Current evidence for BioCore AminoTap is limited to in vitro (laboratory) studies showing increased BCAA and glutamine release from protein sources. These preliminary findings have not yet been validated in human clinical trials, meaning real-world digestive benefits remain unconfirmed. More peer-reviewed research on actual bioavailability in the human body is needed to substantiate manufacturer claims.

Who would benefit most from taking BioCore AminoTap?

BioCore AminoTap may be most relevant for individuals consuming high-protein diets who want to maximize amino acid extraction, particularly those with suboptimal digestive enzyme production or sensitive stomachs. Athletes and muscle-builders seeking enhanced nutrient utilization from protein sources could theoretically benefit, though clinical evidence in these populations is lacking. Those with diagnosed protease deficiencies or digestive disorders may see the most practical application.

Does BioCore AminoTap work across different pH levels in the digestive system?

Laboratory studies indicate that BioCore AminoTap's protease blend maintains enzyme activity throughout the digestive tract without degradation from stomach acid, which is a key advantage over some single-enzyme proteases. This broad pH-range activity suggests the blend is formulated to remain functional in both the acidic stomach and alkaline small intestine environments. However, these findings are based on in vitro conditions and have not been confirmed in human digestive studies.

BioCore AminoTap (Protease blend)

BioCore AminoTap is a proprietary protease enzyme blend engineered to hydrolyze dietary proteins into free amino acids and peptides across the full gastrointestinal pH range. Its constituent serine proteases, metalloproteases, and aspartic proteases cleave peptide bonds at multiple cleavage sites, maximizing release of branched-chain amino acids (BCAAs) and glutamine from intact protein substrates.

Category: Other Evidence: 2/10 Tier: Emerging

BioCore AminoTap (Protease blend) — Hermetica Encyclopedia

Origin & History

BioCore AminoTap is a branded protease blend developed by National Enzyme Company, specifically designed as a powder for sports nutrition and protein hydrolysis to enhance amino acid release from various protein sources. The enzymes are extracted via fermentation processes from fungi such as Aspergillus species, with proteolytic activity measured in units like SAPU, HUT, and PC.

Historical & Cultural Context

No historical or traditional medicine context exists for BioCore AminoTap, as it is a modern branded enzyme blend developed through biotechnology. The product derives from fungal fermentation processes without ties to traditional medicine systems like Ayurveda or TCM.

Health Benefits

• Enhanced amino acid release from protein sources - in vitro studies show exponential increases in BCAA and glutamine release (preliminary evidence only)
• Improved protein digestion across full pH range - laboratory studies confirm enzyme activity throughout digestive system without stomach acid degradation (in vitro evidence)
• Support for muscle-building nutrition - designed to optimize amino acid availability from whey, casein, pea, and other protein sources (mechanistic evidence only)
• Zinc-activated metallopeptidase activity - includes aminopeptidase with zinc for enhanced peptide bond cleavage (theoretical benefit)
• Versatile protein hydrolysis - demonstrated activity with multiple protein types including plant-based sources (in vitro data only)

How It Works

BioCore AminoTap contains a spectrum of proteolytic enzymes—including serine endoproteases (similar to trypsin and chymotrypsin activity), acid-stable aspartic proteases active at gastric pH 2–4, and neutral metalloproteases active at intestinal pH 6–8—that collectively cleave peptide bonds at arginine, lysine, aromatic, and hydrophobic residues. This multi-enzyme activity generates short-chain oligopeptides and free amino acids recognized by intestinal PepT1 transporters and sodium-dependent neutral amino acid transporters (B0AT1/SLC6A19), accelerating luminal absorption. The pH-stable formulation ensures enzymatic activity is not denatured by stomach acid, maintaining catalytic function throughout the duodenum and jejunum.

Scientific Research

No human clinical trials, RCTs, or meta-analyses have been conducted on BioCore AminoTap. Evidence is limited to in vitro studies demonstrating that 250 mg of the product with proteins exponentially increases cumulative release of BCAAs and glutamine. Related BioCore enzyme blends have undergone controlled laboratory testing confirming pH stability, but human data is entirely absent.

Clinical Summary

Evidence for BioCore AminoTap currently rests primarily on manufacturer-sponsored in vitro digestion models and enzyme activity assays rather than randomized controlled human trials, representing a significant limitation in evaluating its clinical utility. In vitro studies using simulated gastrointestinal conditions report exponential increases in measurable BCAA (leucine, isoleucine, valine) and glutamine release compared to protein digested without supplemental proteases, though specific fold-change values and methodology have not been independently replicated in peer-reviewed literature. No published human clinical trials with defined sample sizes, control arms, or bioavailability endpoints currently exist for this specific proprietary blend. Consumers and practitioners should treat all efficacy claims as preliminary until randomized, double-blind, placebo-controlled trials with pharmacokinetic amino acid profiling are conducted.

Nutritional Profile

BioCore AminoTap is a protease enzyme blend with no significant macronutrient or micronutrient contribution at functional dosages (typically 50–500mg per serving). The blend contains no calories, fat, carbohydrates, or fiber in meaningful amounts. The active constituents are proteolytic enzymes — primarily endoproteases and exoproteases derived from microbial, fungal, and/or plant sources (exact strain composition proprietary to BioCore Ingredients). Key bioactive components include acid-stable proteases (active at pH 2.0–4.0, simulating gastric conditions), neutral proteases (active at pH 6.0–7.5, simulating intestinal conditions), and alkaline proteases (active at pH 7.5–9.0), collectively enabling broad-spectrum protein hydrolysis across the full gastrointestinal pH range. In vitro assay data indicates the blend releases measurably elevated concentrations of branched-chain amino acids (leucine, isoleucine, valine) and glutamine from intact protein substrates compared to endogenous digestion alone, though exact liberation rates are substrate-dependent. The blend contains no vitamins or minerals as functional components. Bioavailability note: as enzyme proteins themselves, the proteases are subject to partial self-digestion and denaturation in vivo; enteric-coated or acid-resistant formulations may preserve activity more effectively than standard capsules.

Preparation & Dosage

In vitro studies used 250 mg BioCore AminoTap per protein serving for enhanced BCAA and glutamine release. Related BioCore Enhanced Enzymes use 200 mg per 2 capsules (providing 42,000 HUT, 6,000-8,000 PC, 4 AP, 100 SAPU protease activity), taken 1-2 capsules before meals. No human clinical dosing data available. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Whey protein isolate, BCAAs, L-glutamine, digestive enzyme complex, zinc

Safety & Interactions

Oral protease enzymes are generally recognized as safe (GRAS) when used at recommended servings, with the most commonly reported adverse effects being mild gastrointestinal discomfort, bloating, or nausea, particularly at high doses or when taken without food. Individuals with a known allergy to fungal-derived enzymes (Aspergillus oryzae or A. niger species are common protease sources) should exercise caution, as allergic reactions including urticaria have been documented with similar enzyme products. BioCore AminoTap may theoretically interact with anticoagulant medications such as warfarin, as proteolytic enzymes can exhibit fibrinolytic activity at systemic levels, though oral supplemental doses are unlikely to reach circulation intact. Pregnant or breastfeeding individuals should consult a physician before use due to insufficient safety data for this population, and those with active peptic ulcers or eosinophilic esophagitis should avoid high-dose protease supplements without medical supervision.